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Dr David M. Minion. Thank you and I would like to
congratulate Dr York and the Greenville group on another out-
standing and very thought provoking study. I would also like to
thank them for forwarding the manuscript to me in a timely
manner. It has allowed me to begin the Prozac (Eli Lilly & Co,
Indianapolis, Ind) very early and after nearly 2 weeks of this
medication, I rarely lapse into a catatonic state. It has been over 72
hours since I have spontaneously broke down and began learning
the phrase “mywhole existence is a sham” repeatedly, but I digress.
This study is an important one in that it once again emphasizes or
highlights that rest pain and tissue loss clearly are two separate
entities even though they are often lumped together in terms of
critical limb ischemia.When you focus simply on people with tissue
loss, it is just an extremely challenging cohort of patients, again I
think you have illustrated that well. The paper is also very impor-
tant because it highlights that limb salvage and wound healing are
two different entities. Seventy-three patency rate correlated well
with the 76% limb salvage rate, but wound healing was a soberingpatency and wound healing; in other words, why aren’t these
wounds healing? Are there anatomic factors that you might, for
example, pedal disease as you might hypothesize, might explain
this difference, and perhaps more importantly, do we as vascular
surgeons need to focus more research efforts on advancing wound
care in further efforts for further success with these patients?
Dr York. Thank you for your comments. That number (44%)
struck us as being very odd as well and clearly was out of line with
the other findings that we had. Clearly, there is more to wound
healing than simple revascularization. Often times, patients are not
very compliant, they are not off loaded adequately, and they have
inadequate nutrition, ultimately leading to poor wound healing.
There are a lot of factors that go into the actual healing of
neuropathic wounds or gangrene, so I can’t answer the question
specifically, but again there is more to it than revascularization
alone. Our belief is that discriminating patient selection may be the
single most important consideration in achieving successful out-
comes in patients with tissue loss.
